/Investor DB

Carnrite Ventures — 2022 Investments

2 investments dated 2022 · listed companies and verified rows first · show all

Form Bioformbio.comin𝕏Sep 2022

Form Bio develops AI-driven software and bioinformatics tools for genetic medicine and genome engineering, enabling faster and safer design of gene therapies, protein engineering, and manufacturing optimization.

AI & Machine LearningBiotechDeep TechAustin, US

Benjamin Lamm(Director, Promoter)Andrew Busey(Executive Officer, Director, Promoter)inMichelle Chen, PhD(President & CEO)inDoug DanielsinJoe Nipko, PhDAmicia Elliott, PhD

Co-investorsBold Capital PartnersBreyer CapitalDraper AssociatesForesight CanadaGaingelsJAZZ Venture Partners+2 more

Maximusmaximustribe.cominJul 2022

Maximus is an online telehealth clinic offering clinically-validated, personalized prescription protocols and lab testing focused on health optimization ("performance medicine") for men and women, covering areas like testosterone optimization, medical weight loss, hair regrowth, and stress/sleep support.

Digital HealthHealthtechLongevityWellness & FitnessLos Angeles, US

Saviz Sepah(Executive Officer, Director)S. Cameron Sepah(Founder & CEO)Cameron Sepah(Founder)in

Co-investors10X Capital8VCFounders FundAbstract VenturesChamaeleonGaingels+9 more

Rows marked “SEC filing” are inferred from directors named on the company's SEC Form D — public regulatory data, not a portfolio list published by the firm.